Celnovte Biotechnology

Celnovte Biotechnology Co., Ltd (Celnovte) is specialized in R&D, manufacturing and distribution of pathological diagnostic reagents and instruments. Celnovte has a market-leading portfolio of Immunohistochemistry and in-situ hybridization. Celnovte's MicroStacker™ IHC detection system is renowned for its unsurpassed sensitivity and specificity. Celnovte's PolyStacker™ technology drastically reduces the turnaround time of frozen section IHC experiment to as short as 10mins. Celnovte's SuperISH™ RNA in-situ hybridization technology enables detection of RNA targets at the single molecular level and single cell resolution. Celnovte is also leading in its innovation of fully automated instrumentation, such as IHC stainers (CNT300/330/360), H&E stainer, special stainer, cytopathology instrumentation and digital slide scanner and etc. Since their launch in 2018, Celnovte have successfully installed over 800 units of fully automated IHC stainers globally. CE IVDR, FDA, ISO9001, ISO13485 certified.